Neural and Physiological Correlates of Psychedelic Sub-states (i2)

This open-label trial (n=12) will test repeated doses of psilocybin (first 10mg, then 3x 25mg; at least 7 days apart) and employ MRI scans to discover reliable brand and body reactions during the psychedelic experience. Specific to this study is that every 100 seconds participants will be asked about their rating (valence) of the experience.

Topic Neuroscience Healthy Subjects
Compound Psilocybin
Country United States of America
Visit trial

Trial Details



Trial Number

Sponsors & Collaborators

University of California San Francisco
At UCSF, there are two research teams dedicated to the study of psychedelics; the Neuroscape Psychedelic Division and the Translational Psychedelic Research Program.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.